BRIC Countries Present the Most Exciting Opportunity for Pharmaceutical Companies - but Only to Those Who Can Properly Evaluate the Market and Plan Effectively.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c33165) has announced the addition of the new Espicom Business Intelligence report "The Market for Pharmaceuticals in Brazil, Russia, India & China" to their offering.

Evaluate the status, opportunities and threats for pharmaceutical companies in Brazil, Russia, India and China now and in the future. This report includes market forecasts to 2010 plus three quarterly-updated market Outlook Reports on each country, keeping you up to date with developments for a full year.

Many claim the BRIC countries present the most exciting opportunity for pharmaceutical companies - but only to those who can properly evaluate the market and plan effectively.

For years the huge markets of Brazil, Russia, India and China (the BRIC economies) have promised much and delivered little. On going political and economic issues have held them back from realising their true potential in the global market. But is all that set to change?

Consider the long term...

--In less than 40 years time, the BRIC's economies together could be larger than the G6 in US dollar terms

--By 2025 they could account for over half the size of the G6 - currently they are worth less than 15%

--In US dollar terms, China could overtake Germany in the next four years, Japan by 2015 and the US by 2039

--Of the current G6 (US, Japan, Germany, France, Italy and the UK) only the US and Japan may be among the six largest economies in US dollar terms in 2050

This is evolution not revolution, and change will be progressive. Common characteristics to be found among the four markets include low levels of health expenditure, wide unmet clinical and social need and variable health provision. The real opportunities lay in the future, where steady growth in BRIC markets will erode the commercial differences with the established markets of North America, Japan and Europe.

Effective planning is vital, and impartial, thoroughly researched information is essential to fully appreciate the current status as a basis for future development. In addition to highly detailed chapters on each market, the report provides a thought-provoking and comparative examination of the BRIC economies, putting opportunities into their current and future context.

Topics covered include:

--BRIC Overview

--Geographic Data

--Political Data

--Economic Data

--Demographics

--Healthcare Data

--Market Data

--Brazil

--Russia

--India

--China

For more information visit http://www.researchandmarkets.com/reports/c33165